The Science of Promise.

We believe that science is the key to curing ovarian cancer in all women. The science employed in clinical trials compares the currently recognized, best available standard of care with a new treatment that holds the promise of being safer or more effective, offering alternatives for those who suffer from ovarian cancer.

Though clinical trials are an important part of research and care of women with ovarian cancer, many people have misconceptions about what these trials are, and the types of treatments available. We encourage you to learn about the options available to you as early as possible during treatment.

Click here to learn more about clinical trials and ovarian cancer.

Or, you can simply begin your search for a clinical trial today.

Spotlight

 

Introducing Ovarian Cancer Research Fund's 2012 Grantees! | This year, OCRF will award $5.4 million in research grants to 14 scientists at leading medical institutions across the country. Read More.

 

Valentine's Day Shop | This Valentine's Day, choose candles, wine, flowers, jewelry and cards to warm the hearts of your family and friends. Read More.

Spotlight Slide One

Ovarian Cycle Rides to Support Research | This indoor cycling event with a unique fundraising program kicks off its 2012 season in Dallas. Read More.

Spotlight Slide One

Join Kelly Ripa and Electrolux on the Search for America's Favorite Comfort Food! | Select your comfort food favorite, and Electrolux will donate $1 to OCRF! Read More.

 

Gold Buyers America/Gold Rush Partnership | Gold Buyers America/Gold Rush recently kicked off this unique new partnership with a contribution of $10,800. Read More.

Events

  • January 27, 2012"Teal Out": Petersburg, MI. Read more.
  • January 28, 2012"Project Hercules" Polar Bear Plunge: Annapolis, MD. Read more.
  • February 1, 2012Amrita Singh Exclusive Sale: New York, NY. Read more.

Stories of Hope

Enduring For Ovarian Cancer Since 2009, a dedicated group of friends and family of Jackie Bayley, who lost her battle with ovarian cancer, have been raising fund for research.
Meet the team making a difference.

Meet a Researcher

Meet a Researcher Selvendiran Karuppaiyah, PhD, a 2011 Liz Tilberis Awardee, is developing novel synthetic drugs for selective targets of ovarian cancer cells.
Find out about his current project.